-
Company Profile
Imunon Inc – Company Profile
Imunon Inc (Imunon), formerly Celsion Corp is a clinical-stage oncology company with a focus on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA and DNA based therapies and immunotherapies. The company develops drugs using its three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in Phase III clinical trial for the treatment of primary liver cancer. It is also developing...
Add to Basket -
Product Insights
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fallopian Tube Cancer symptoms may include abnormal vaginal bleeding, especially after menopause, abdominal pain or a feeling of pressure in the abdomen, abnormal vaginal discharge that is white, clear or pinkish and a pelvic mass at the time of diagnosis. The Fallopian Tube Cancer pipeline drugs market research report provides an analysis of the Fallopian Tube Cancer drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the...
-
Product Insights
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Drugs In Development, 2022, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood...
-
Product Insights
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peritoneal cancer develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus, and extends over the bladder and rectum. Peritoneal cancer usually manifests with abdominal distention and diffuse nonspecific abdominal pain secondary to ascites. Peritoneal cancer symptoms may include shortness of breath, rectal bleeding, loss of appetite, frequent urination, constipation, nausea or diarrhea, and feeling of fullness, even after a light meal. Treatment includes options such as chemotherapy, surgery, biological...
-
Product Insights
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pulmonary arterial hypertension pipeline market research report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Arterial Hypertension and...
-
Sector Analysis
Outlook for Viral Vector Contract Manufacturing – Gene Therapies, Cell Therapies, and COVID-19 Vaccines
The bio/pharmaceutical industry is experiencing a shortage of viral vectors, a component needed to produce gene therapies and gene-modified cell therapies, as well as certain COVID-19 vaccines that require a viral vector, notably those from AstraZeneca and Johnson & Johnson (J&J). This report reveals that viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities. There are 14 therapies/vaccines that use a viral vector (gene therapies, gene-modified cell therapies, and...
-
Product Insights
Wilms’ Tumor (Nephroblastoma) Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2020" provides an overview of Wilms' Tumor (Nephroblastoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Wilms' Tumor (Nephroblastoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Wilms Tumor (Nephroblastoma) Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2020" provides an overview of Wilms' Tumor (Nephroblastoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Wilms' Tumor (Nephroblastoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Wilms’ Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2018" provides an overview of Wilms' Tumor (Nephroblastoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Wilms' Tumor (Nephroblastoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Pediatric Cancer Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Pediatric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pediatric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...